Atlas Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49K | Buy |
+110
| New | +$49K | 0.01% | 628 |
|
|
2023
Q1 | – | Sell |
-162
| Closed | -$46.8K | – | 964 |
|
|
2022
Q4 | $46.8K | Sell |
162
-4
| -2% | -$1.16K | 0.01% | 548 |
|
|
2022
Q3 | $48.1K | Buy |
166
+2
| +1% | +$579 | 0.01% | 540 |
|
|
2022
Q2 | $46.2K | Buy |
+164
| New | +$46.2K | 0.01% | 573 |
|
|
2022
Q1 | – | Sell |
-5
| Closed | -$1.1K | – | 970 |
|
|
2021
Q4 | $1.1K | Hold |
5
| – | – | ﹤0.01% | 873 |
|
|
2021
Q3 | $906 | Hold |
5
| – | – | ﹤0.01% | 896 |
|
|
2021
Q2 | $1.01K | Buy |
+5
| New | +$1.01K | ﹤0.01% | 900 |
|